These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 16166303)
1. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Simonson SJ; Difilippantonio MJ; Lambert PF Cancer Res; 2005 Sep; 65(18):8266-73. PubMed ID: 16166303 [TBL] [Abstract][Full Text] [Related]
2. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. Nguyen ML; Nguyen MM; Lee D; Griep AE; Lambert PF J Virol; 2003 Jun; 77(12):6957-64. PubMed ID: 12768014 [TBL] [Abstract][Full Text] [Related]
3. Dominant role of HPV16 E7 in anal carcinogenesis. Thomas MK; Pitot HC; Liem A; Lambert PF Virology; 2011 Dec; 421(2):114-8. PubMed ID: 21999991 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Song S; Liem A; Miller JA; Lambert PF Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Maufort JP; Williams SM; Pitot HC; Lambert PF Cancer Res; 2007 Jul; 67(13):6106-12. PubMed ID: 17616666 [TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Shai A; Brake T; Somoza C; Lambert PF Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103 [TBL] [Abstract][Full Text] [Related]
7. The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouse. Popoca-Cuaya M; Diaz-Chavez J; Hernandez-Monge J; Alvarez-Rios E; Lambert PF; Gariglio P Exp Dermatol; 2015 Jun; 24(6):430-5. PubMed ID: 25776923 [TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. Song S; Pitot HC; Lambert PF J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340 [TBL] [Abstract][Full Text] [Related]
9. Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes. Kang JK; Kim JH; Lee SH; Kim DH; Kim HS; Lee JE; Seo JS Cancer Lett; 2000 Nov; 160(2):177-83. PubMed ID: 11053647 [TBL] [Abstract][Full Text] [Related]
10. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828 [TBL] [Abstract][Full Text] [Related]
12. A mouse model for human anal cancer. Stelzer MK; Pitot HC; Liem A; Schweizer J; Mahoney C; Lambert PF Cancer Prev Res (Phila); 2010 Dec; 3(12):1534-41. PubMed ID: 20947489 [TBL] [Abstract][Full Text] [Related]
13. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins. Park JW; Shin MK; Pitot HC; Lambert PF PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435 [TBL] [Abstract][Full Text] [Related]
14. DMBA/TPA-induced tumor formation is aggravated in human papillomavirus type 16 E6/E7 transgenic mouse skin. Kim MO; Kim SH; Shin MJ; Yu DH; Kim BS; Chang KT; Lee S; Park YB; Lee TH; Ryoo ZY Oncol Res; 2007; 16(7):325-32. PubMed ID: 17518270 [TBL] [Abstract][Full Text] [Related]
15. The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo. Bonilla-Delgado J; Bulut G; Liu X; Cortés-Malagón EM; Schlegel R; Flores-Maldonado C; Contreras RG; Chung SH; Lambert PF; Uren A; Gariglio P Mol Cancer Res; 2012 Feb; 10(2):250-8. PubMed ID: 22160870 [TBL] [Abstract][Full Text] [Related]
16. A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. Nguyen M; Song S; Liem A; Androphy E; Liu Y; Lambert PF J Virol; 2002 Dec; 76(24):13039-48. PubMed ID: 12438630 [TBL] [Abstract][Full Text] [Related]
17. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Shai A; Pitot HC; Lambert PF Cancer Res; 2010 Jun; 70(12):5064-73. PubMed ID: 20530688 [TBL] [Abstract][Full Text] [Related]
18. Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. White EA; Kramer RE; Hwang JH; Pores Fernando AT; Naetar N; Hahn WC; Roberts TM; Schaffhausen BS; Livingston DM; Howley PM J Virol; 2015 Mar; 89(5):2857-65. PubMed ID: 25540383 [TBL] [Abstract][Full Text] [Related]
19. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Schaeffer AJ; Nguyen M; Liem A; Lee D; Montagna C; Lambert PF; Ried T; Difilippantonio MJ Cancer Res; 2004 Jan; 64(2):538-46. PubMed ID: 14744767 [TBL] [Abstract][Full Text] [Related]
20. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers. Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]